{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:04:29Z","timestamp":1778839469738,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1007\/s11936-004-0003-x","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T09:27:55Z","timestamp":1180862875000},"page":"459-469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Management of the patient after heart transplant"],"prefix":"10.1007","volume":"6","author":[{"given":"Michael A.","family":"Mathier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis M.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S1053-2498(03)00186-4","volume":"22","author":"DO Taylor","year":"2003","unstructured":"Taylor DO, Edwards LB, Mohacsi PJ, et al.: The Registry of the International Society for Heart and Lung Transplantation: Twentieth Official Adult Heart Transplant Report-2003. J Heart Lung Transplant 2003, 22:616\u2013624. The most recent report from the International Society for Heart and Lung Transplantation registry on adult heart transplant. Reviews trends in volume, patient and donor characteristics, and outcomes, including the relative importance of various post-transplant medical conditions.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR2","unstructured":"International Society for Heart and Lung Transplant. http:\/www.ishlt.org\/registries\/. Accessed June 1, 2004."},{"key":"3_CR3","first-page":"374","volume":"17","author":"WM Brann","year":"1998","unstructured":"Brann WM, Bennett LE, Keck BM, Hosenpud JD: Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the Joint International Society for Heart and Lung Transplantation\/United Network for Organ Sharing Thoracic Registry. J Heart Lung Transplant 1998, 17:374\u2013382.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJM199509073331003","volume":"333","author":"JA Kobashigawa","year":"1995","unstructured":"Kobashigawa JA, Katznelson S, Laks H, et al.: Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995, 333:621\u2013627.","journal-title":"N Engl J Med"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1053-2498(00)00249-7","volume":"20","author":"J Jimenez","year":"2001","unstructured":"Jimenez J, Kapadia SR, Yamani MH, et al.: Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study. J Heart Lung Transplant 2001, 20:393\u2013398.","journal-title":"J Heart Lung Transplant"},{"issue":"5 suppl","key":"3_CR6","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.1016\/j.healun.2004.03.009","volume":"23","author":"H Valantine","year":"2004","unstructured":"Valantine H: Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant 2004, 23(5 suppl):S187-S193. A thorough review of the current status of graft coronary disease.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/00007890-200203150-00018","volume":"73","author":"AK Subramanian","year":"2002","unstructured":"Subramanian AK, Quinn TC, Kickler TS, et al.: Correlation of chlamydia pneumoniae infection and severity of accelerated graft arteriosclerosis after cardiac transplantation. Transplantation 2002, 73:761\u2013764.","journal-title":"Transplantation"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1378\/chest.116.2.332","volume":"116","author":"M Schwaiblmair","year":"1999","unstructured":"Schwaiblmair M, von Scheidt W, Uberfuhr P, et al.: Lung function and cardiopulmonary exercise performance after heart transplantation: influence of cardiac allograft vasculopathy. Chest 1999, 116:332\u2013339.","journal-title":"Chest"},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S1053-2498(02)00413-8","volume":"21","author":"JM Aranda","year":"2002","unstructured":"Aranda JM, Pauly DF, Kerensky RA, et al.: Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy. J Heart Lung Transplant 2002, 21:860\u2013866.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1053-2498(00)00115-7","volume":"19","author":"B Schnetzler","year":"2000","unstructured":"Schnetzler B, Drobinski G, Dorent R, et al.: The role of percutaneous transluminal coronary angioplasty in heart transplant recipients. J Heart Lung Transplant 2000, 19:557\u2013565.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/S0041-1345(00)02702-0","volume":"33","author":"M Cardillo","year":"2001","unstructured":"Cardillo M, Rossini G, Scalamogna M, et al.: Tumor incidence in heart transplant patients: report of the North Italy Transplant Program Registry. Transplant Proc 2001, 33:1840\u20131843.","journal-title":"Transplant Proc"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1053-2498(99)00137-0","volume":"19","author":"AB Fortina","year":"2000","unstructured":"Fortina AB, Caforio AL, Piaserico S, et al.: Skin cancer in heart transplant recipients: frequency and risk factor analysis. J Heart Lung Transplant 2000, 19:249\u2013255.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/01.TP.0000044135.92850.75","volume":"75","author":"GBE Jemec","year":"2003","unstructured":"Jemec GBE, Holm EA: Nonmelanoma skin cancer in organ transplant patients. Transplantation 2003, 75:253\u2013257.","journal-title":"Transplantation"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S1053-2498(02)01229-9","volume":"22","author":"SZ Gao","year":"2003","unstructured":"Gao SZ, Chaparro SV, Perlroth M, et al.: Post-transplantation lymphoproliferative disease in heart and heartlung transplant recipients: 30-year experience at Stanford University. J Heart Lung Transplant 2003, 22:505\u2013514.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0022-5223(03)00055-2","volume":"126","author":"P Demers","year":"2003","unstructured":"Demers P, Moffatt S, Oyer PE, et al.: Long-term results of heart transplantation in patients older than 60 years. J Thorac Cardiovasc Surg 2003, 126:224\u2013231.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"suppl 3","key":"3_CR16","first-page":"III222","volume":"102","author":"AL Caforio","year":"2000","unstructured":"Caforio AL, Fortina AB, Piaserico S, et al.: Skin cancer in heart transplant recipients. Circulation 2000, 102(suppl 3):III222-III227.","journal-title":"Circulation"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S1053-2498(00)00326-0","volume":"20","author":"ND Zilz","year":"2001","unstructured":"Zilz ND, Olson LJ, McGregor CG: Treatment of posttransplant lymphoproliferative disorder with monoclonal CD20 antibody (rituximab) after heart transplantation. J Heart Lung Transplant 2001, 20:770\u2013772.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S1053-2498(98)00060-6","volume":"18","author":"DO Taylor","year":"1999","unstructured":"Taylor DO, Barr ML, Radovancevic B, et al.: A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 1999, 18:336\u2013345.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","volume":"66","author":"J Kobashigawa","year":"1998","unstructured":"Kobashigawa J, Miller L, Relund D, et al.: A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Transplantation 1998, 66:507\u2013515.","journal-title":"Transplantation"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/01.CIR.0000070421.38604.2B","volume":"108","author":"D Mancini","year":"2003","unstructured":"Mancini D, Pinney S, Burkhoff D, et al.: Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003, 108:48\u201353.","journal-title":"Circulation"},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1053-2498(00)00096-6","volume":"19","author":"RH Rubin","year":"2000","unstructured":"Rubin RH: Prevention and treatment of cytomegalovirus disease in heart transplant patients. J Heart Lung Transplant 2000, 19:731\u2013735.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11908-002-0019-x","volume":"4","author":"S Keay","year":"2002","unstructured":"Keay S: Cardiac transplantation: pre-transplant infectious diseases evaluation and post-transplant prophylaxis. Curr Infect Dis Rep 2002, 4:285\u2013292. An exhaustive review of current understanding and practice patterns for the management of the infectious complications of cardiac transplantation and immunosuppression.","journal-title":"Curr Infect Dis Rep"},{"key":"3_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S1053-2498(01)00399-0","volume":"21","author":"JJ Egan","year":"2002","unstructured":"Egan JJ, Carroll KB, Yonan N, et al.: Valacyclovir prevention of cytomegalovirus reactivation after heart transplantation: a randomized trial. J Heart Lung Transplant 2002, 21:460\u2013466.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0735-1097(02)02821-8","volume":"41","author":"HJ Eisen","year":"2003","unstructured":"Eisen HJ: Hypertension in heart transplant recipients: more than just cyclosporine. J Am Coll Cardiol 2003, 41:433\u2013434.","journal-title":"J Am Coll Cardiol"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/S0735-1097(97)82757-X","volume":"29","author":"AK Andreassen","year":"1997","unstructured":"Andreassen AK, Hartmann A, Offstad J, et al.: Hypertension prophylaxis with omega-3 fatty acids in heart transplant recipients. J Am Coll Cardiol 1997, 29:1324\u20131331.","journal-title":"J Am Coll Cardiol"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/0735-1097(96)00057-5","volume":"27","author":"SC Brozena","year":"1996","unstructured":"Brozena SC, Johnson MR, Ventura H, et al.: Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. J Am Coll Cardiol 1996, 27:1707\u20131712.","journal-title":"J Am Coll Cardiol"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1053-2498(02)00567-3","volume":"22","author":"CC Lang","year":"2003","unstructured":"Lang CC, Beniaminovitz A, Edwards N, Mancini DM: Morbidity and mortality in diabetic patients following cardiac transplantation. J Heart Lung Transplant 2003, 22:244\u2013249.","journal-title":"J Heart Lung Transplant"},{"issue":"5 suppl","key":"3_CR28","doi-asserted-by":"publisher","first-page":"S194","DOI":"10.1016\/j.healun.2004.03.007","volume":"23","author":"P Marchetti","year":"2004","unstructured":"Marchetti P: New-onset diabetes after transplantation. J Heart Lung Transplant 2004, 23(5 suppl):S194-S201.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR29","doi-asserted-by":"publisher","first-page":"SS3","DOI":"10.1097\/01.TP.0000069952.49242.3E","volume":"75","author":"J Davidson","year":"2003","unstructured":"Davidson J, Wilkinson A, Dantal J, et al.: New-onset diabetes after transplantation: 2003 International Consensus Guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003, 75(suppl):SS3-S24.","journal-title":"Transplantation"},{"key":"3_CR30","first-page":"1258","volume":"73","author":"A Fatemeh","year":"2003","unstructured":"Fatemeh A, Jackson CH, Parameshwar J, et al.: Risk factors for the development and progression of dyslipidemia after heart transplantation. Transplantation 2003, 73:1258\u20131264.","journal-title":"Transplantation"},{"key":"3_CR31","first-page":"613","volume":"14","author":"PW Pflugfelder","year":"1995","unstructured":"Pflugfelder PW, Huff M, Oskalns R, et al.: Cholesterollowering therapy after heart transplantation: a 12-month randomized trial. J Heart Lung Transplant 1995, 14:613\u2013622.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1161\/01.CIR.0000043241.32523.EE","volume":"107","author":"K Wenke","year":"2003","unstructured":"Wenke K, Meiser B, Thiery J, et al.: Simvastatin initiated early after heart transplantation. Circulation 2003, 107:93\u201397.","journal-title":"Circulation"},{"key":"3_CR33","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1053-2498(00)00077-2","volume":"19","author":"A Keogh","year":"2000","unstructured":"Keogh A, Macdonald P, Kaan A, et al.: Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation. J Heart Lung Transplant 2000, 19:529\u2013537.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0041-1345(01)02718-X","volume":"34","author":"LA Bonet","year":"2002","unstructured":"Bonet LA, Martinez-Dolz L, Vives MA, et al.: Lipidlowering effect of atorvastatin in heart transplantation. Transplant Proc 2002, 34:179\u2013181.","journal-title":"Transplant Proc"},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S0735-1097(01)01430-9","volume":"38","author":"M Weis","year":"2001","unstructured":"Weis M, Pehlivanli S, Meiser BM, von Scheidt W: Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation. J Am Coll Cardiol 2001, 38:814\u2013818.","journal-title":"J Am Coll Cardiol"},{"key":"3_CR36","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJMoa022171","volume":"349","author":"HJ Eisen","year":"2003","unstructured":"Eisen HJ, Tuzcu EM, Dorent R, et al.: Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003, 349:847\u2013858.","journal-title":"N Engl J Med"},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.amjcard.2003.08.075","volume":"93","author":"AA Doshi","year":"2004","unstructured":"Doshi AA, Rogers J, Kern MJ, Hauptman PJ: Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy. Am J Cardiol 2004, 93:90\u201392.","journal-title":"Am J Cardiol"},{"key":"3_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ccd.10607","volume":"60","author":"MA Grise","year":"2003","unstructured":"Grise MA, Reilly JP, Tobis JM, et al.: Intracoronary radiation to treat in-stent restenosis in six cardiac transplant patients. Catheter Cardiovasc Interv 2003, 60:41\u201344.","journal-title":"Catheter Cardiovasc Interv"},{"key":"3_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1046\/j.0886-0440.2003.02066.x","volume":"18","author":"M Ono","year":"2003","unstructured":"Ono M, Michler RE: Beating heart coronary artery bypass surgery after orthotopic heart transplantation. J Card Surg 2003, 18:545\u2013549.","journal-title":"J Card Surg"},{"key":"3_CR40","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0003-4975(03)01164-0","volume":"77","author":"I Aleksic","year":"2004","unstructured":"Aleksic I, Piotrowski JA, Kamler M, et al.: Minimally invasive direct coronary artery bypass in a cardiac transplant recipient with allograft vasculopathy. Ann Thorac Surg 2004, 77:1433\u20131434.","journal-title":"Ann Thorac Surg"},{"key":"3_CR41","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/S1053-2498(02)00803-3","volume":"22","author":"B Radovancevic","year":"2003","unstructured":"Radovancevic B, McGiffin DC, Kobashigawa JA, et al.: Reptransplantation in 7,290 primary transplant patients: a 10-year multi-institutional study. J Heart Lung Transplant 2003, 22:862\u2013868.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0272-6386(95)90174-4","volume":"26","author":"V Sehgal","year":"1995","unstructured":"Sehgal V, Radhakrishnan J, Appel GB, et al.: Progressive renal insufficiency following cardiac transplantation: cyclosporine, lipids and hypertension. Am J Kidney Dis 1995, 26:193\u2013201.","journal-title":"Am J Kidney Dis"},{"key":"3_CR43","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/S1053-2498(02)00412-6","volume":"21","author":"MR Vossler","year":"2002","unstructured":"Vossler MR, Ni H, Toy W, Hershberger RE: Pre-operative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation. J Heart Lung Transplant 2002, 21:874\u2013881.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR44","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/00007890-199703150-00009","volume":"63","author":"DJ Goldstein","year":"1997","unstructured":"Goldstein DJ, Zuech N, Sehgal V, et al.: Cyclosporineassociated end-stage nephropathy after cardiac transplantation: incidence and progression. Transplantation 1997, 63:664\u2013668.","journal-title":"Transplantation"},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/S0041-1345(98)00177-8","volume":"30","author":"T Van Gelder","year":"1998","unstructured":"Van GelderT, Balk AH, Zietse R, et al.: Survival of heart transplant recipients with cyclosporine-induced renal insufficiency. Transplant Proc 1998, 30:1122\u20131123.","journal-title":"Transplant Proc"},{"key":"3_CR46","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1053-2498(01)00411-9","volume":"21","author":"DK Satchithananda","year":"2002","unstructured":"Satchithananda DK, Parameshwar J, Sharples L, et al.: The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience. J Heart Lung Transplant 2002, 21:651\u2013657.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR47","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/S0041-1345(02)03104-4","volume":"34","author":"DA Baran","year":"2002","unstructured":"Baran DA, Galin ID, Sandler D, et al.: Predictors of early renal insufficiency in cardiac transplant recipients initiated on tacrolimus. Transplant Proc 2002, 34:1872\u20131873.","journal-title":"Transplant Proc"},{"key":"3_CR48","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/01.TP.0000103740.98095.14","volume":"77","author":"J Groetzner","year":"2004","unstructured":"Groetzner J, Meiser B, Landwehr P, et al.: Mycophenolate mofetil and sirolimus as calcineurin inhibitorfree immunosuppression for late cardiac-transplant recipients with chronic renal failure. Transplantation 2004, 77:568\u2013574.","journal-title":"Transplantation"},{"key":"3_CR49","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S1053-2498(01)00421-1","volume":"21","author":"GI Snell","year":"2002","unstructured":"Snell GI, Levvey BJ, Chin W, et al.: Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment. J Heart Lung Transplant 2002, 21:540\u2013546.","journal-title":"J Heart Lung Transplant"},{"key":"3_CR50","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1093\/ndt\/13.11.2905","volume":"13","author":"L Frimat","year":"1998","unstructured":"Frimat L, Villemot JP, Cormier L, et al.: Treatment of end-stage renal failure after heart transplantation. Nephrol Dial Transplant 1998, 13:2905\u20132908.","journal-title":"Nephrol Dial Transplant"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-004-0003-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11936-004-0003-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-004-0003-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-004-0003-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:05:44Z","timestamp":1659092744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11936-004-0003-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1007\/s11936-004-0003-x","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}